RCKT ROCKET PHARMACEUTICALS INC

Ownership history in Boxer Capital, LLC  ·  28 quarters on record

This page tracks every 13F SEC filing in which Boxer Capital, LLC reported a position in ROCKET PHARMACEUTICALS INC (RCKT). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
5.37% (2018 Q3)
Avg. % of fund
2.03%
First filed
2018 Q1
Last filed
2024 Q4
Quarters held
28
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2024 Q4 UNCHANGED 1,466,051 0% 1.33% $27.1M $12.57
2024 Q3 UNCHANGED 1,466,051 0% 1.33% $27.1M $18.47
2024 Q2 UNCHANGED 1,466,051 0% 1.66% $31.6M $21.53
2024 Q1 UNCHANGED 1,466,051 0% 1.95% $39.5M $26.94
2023 Q4 UNCHANGED 1,466,051 0% 2.19% $43.9M $29.97
2023 Q3 UNCHANGED 1,466,051 0% 1.60% $30.0M $20.49
2023 Q2 UNCHANGED 1,466,051 0% 1.35% $29.1M $19.87
2023 Q1 UNCHANGED 1,466,051 0% 1.23% $25.1M $17.13
2022 Q4 UNCHANGED 1,466,051 0% 1.51% $28.7M $19.57
2022 Q3 UNCHANGED 1,466,051 0% 1.32% $23.4M $15.96
18 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    RCKT price (monthly, adj. close)
← Back to Boxer Capital, LLC Holdings